SAC Capital Slashes Stake in Intercept Pharmaceuticals (ICPT) to Near 0%

In an amended 13G filing on Intercept Pharmaceuticals (NASDAQ: ICPT), Steven Cohen's hedge fund SAC Capital disclosed a 0.03%, or 6,123 share, stake in the company. This is down 99.55% from the 1,369,046 shares held at the end of the latest quarter.

For more notable holders of Intercept Pharmaceuticals stock click here. For more information on SAC Capital click here.

You May Also Be Interested In

• Bessent: Think Druckenmiller Lost Money Day He Sent Editorial
• Enbridge forms C$2.7B joint venture with KKR and Apollo
• Industrial Physics acquires Vitrek from Branford Castle